NO20031140L - 2-amino-2-alkyl-5-hepten- og heptynsyrederivater som er anvendbare som nitrogenoksydsyntase-inhibitorer - Google Patents

2-amino-2-alkyl-5-hepten- og heptynsyrederivater som er anvendbare som nitrogenoksydsyntase-inhibitorer

Info

Publication number: NO20031140L
Authority: NO; Norway
Prior art keywords: heptenic; amino; alkyl; acid derivatives; nitric oxide
Prior art date: 2000-09-15

Application number

NO20031140A

Other languages

English (en)

Other versions

NO20031140D0 (no

Inventor

Jr Donald Hansen

Ronald Keith Webber

Barnett S Pitzele

James Sikorski

Mark A Massa

Timothy J Hagen

Margaret Grapperhaus

Lijuan Jane Wang

Arija A Bergmanis

Steven W Kramer

Eleanor Ann Hallinan

Original Assignee

Pharmacia Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-15

Filing date

2003-03-12

Publication date

2003-05-08

2003-03-12 Application filed by Pharmacia Corp filed Critical Pharmacia Corp

2003-03-12 Publication of NO20031140D0 publication Critical patent/NO20031140D0/no

2003-05-08 Publication of NO20031140L publication Critical patent/NO20031140L/no

Links

239000002253 acid Substances 0.000 title 1
239000000236 nitric oxide synthase inhibitor Substances 0.000 title 1
CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20031140A 2000-09-15 2003-03-12 2-amino-2-alkyl-5-hepten- og heptynsyrederivater som er anvendbare som nitrogenoksydsyntase-inhibitorer NO20031140L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23268300P	2000-09-15	2000-09-15
PCT/US2001/028673 WO2002022562A1 (en)	2000-09-15	2001-09-15	2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors

Publications (2)

Publication Number	Publication Date
NO20031140D0 NO20031140D0 (no)	2003-03-12
NO20031140L true NO20031140L (no)	2003-05-08

Family

ID=22874118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031140A NO20031140L (no)	2000-09-15	2003-03-12	2-amino-2-alkyl-5-hepten- og heptynsyrederivater som er anvendbare som nitrogenoksydsyntase-inhibitorer

Country Status (26)

Country	Link
US (2)	US6951889B2 (no)
EP (1)	EP1317421B1 (no)
JP (1)	JP5009480B2 (no)
KR (1)	KR100840981B1 (no)
CN (1)	CN1301966C (no)
AR (1)	AR030741A1 (no)
AT (1)	ATE289587T1 (no)
AU (2)	AU2001290883A1 (no)
BR (1)	BR0113925A (no)
CA (1)	CA2421504C (no)
CY (1)	CY1106056T1 (no)
CZ (1)	CZ2003646A3 (no)
DE (1)	DE60109046T2 (no)
DK (1)	DK1317421T3 (no)
EA (1)	EA006244B1 (no)
ES (1)	ES2238477T3 (no)
IL (2)	IL154841A0 (no)
MX (1)	MXPA03002207A (no)
MY (1)	MY131964A (no)
NO (1)	NO20031140L (no)
NZ (1)	NZ524562A (no)
PL (1)	PL207391B1 (no)
PT (1)	PT1317421E (no)
SI (1)	SI1317421T1 (no)
TW (1)	TWI290130B (no)
WO (1)	WO2002022562A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR032318A1 (es) *	2000-04-13	2003-11-05	Pharmacia Corp	Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
US8022058B2 (en)	2000-05-10	2011-09-20	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the RyR receptors
US7312044B2 (en)	2003-03-07	2007-12-25	The Trustees Of Columbia University In The City Of New York	Type 1 ryanodine receptor-based methods
US7879840B2 (en)	2005-08-25	2011-02-01	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the RyR receptors
US20040048780A1 (en) *	2000-05-10	2004-03-11	The Trustees Of Columbia University In The City Of New York	Method for treating and preventing cardiac arrhythmia
US7393652B2 (en)	2000-05-10	2008-07-01	The Trustees Of Columbia University In The City Of New York	Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7718644B2 (en)	2004-01-22	2010-05-18	The Trustees Of Columbia University In The City Of New York	Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040229781A1 (en) *	2000-05-10	2004-11-18	Marks Andrew Robert	Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US6489125B1 (en) *	2000-05-10	2002-12-03	The Trustees Of Columbia University In The City Of New York	Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20060293266A1 (en) *	2000-05-10	2006-12-28	The Trustees Of Columbia	Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
AU2003232148A1 (en) *	2002-05-16	2003-12-02	Pharmacia Corporation	A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
CN1652843A (zh) *	2002-05-16	2005-08-10	法玛西雅公司	使用选择性iNOS抑制剂治疗呼吸系统疾病和病症
KR20050059051A (ko) *	2002-08-02	2005-06-17	파마시아 코포레이션	위장 증상의 치료 및 예방 방법
ES2384969T3 (es)	2002-08-23	2012-07-16	Pharmacia Corporation	Forma sólida cristalina del ácido (2S-5Z)-2-amino-7-(etanimidoilamino)-2-metilhept-5-enoico
US7544678B2 (en)	2002-11-05	2009-06-09	The Trustees Of Columbia University In The City Of New York	Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
US20040235139A1 (en) *	2002-12-23	2004-11-25	Demain Arnold L.	Clostridium difficile culture and toxin production methods
US8710045B2 (en)	2004-01-22	2014-04-29	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CA2611105A1 (en) *	2005-06-09	2006-12-21	Mallinckrodt Inc.	Method for separation and purification of naltrexone by preparative chromatography
US7704990B2 (en)	2005-08-25	2010-04-27	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the RyR receptors
AR059224A1 (es) *	2006-01-31	2008-03-19	Jerini Ag	Compuestos para la inhibicion de integrinas y uso de estas
US9895324B2 (en) *	2014-03-26	2018-02-20	University Of Kentucky Research Foundation	Halogenated diarylacetylenes and methods of treating cancer
GB201512635D0 (en)	2015-07-17	2015-08-26	Ucl Business Plc	Uses of therapeutic compounds
EP3398941A1 (en) *	2017-05-03	2018-11-07	AXXAM S.p.A.	Heterocyclic p2x7 antagonists
CN113861064B (zh) *	2021-10-14	2024-05-10	南京医科大学	一类神经保护剂及其药物用途
CN116693389B (zh) *	2023-06-15	2025-09-23	新元果业(山东)集团有限公司	一种合成番茄潜叶蛾性信息素(3e,8z)-3,8-十四碳二烯乙酸酯的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5132453A (en)	1991-03-22	1992-07-21	Cornell Research Foundation, Inc.	N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
JP2648897B2 (ja)	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
GB9127376D0 (en) *	1991-12-24	1992-02-19	Wellcome Found	Amidino derivatives
GB9203347D0 (en)	1992-02-17	1992-04-01	Wellcome Found	Hypolipidaemic compounds
EP0751930B1 (en)	1994-03-24	2000-01-05	G.D. SEARLE & CO.	Amidino derivatives useful as nitric oxide synthase inhibitors
US5994391A (en)	1994-09-13	1999-11-30	G.D. Searle And Company	Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5684008A (en)	1994-11-09	1997-11-04	G. D. Searle & Co.	Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
GB9516709D0 (en)	1995-08-15	1995-10-18	Zeneca Ltd	Medicament
US5945408A (en) *	1996-03-06	1999-08-31	G.D. Searle & Co.	Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) *	1997-07-22	1999-11-09	G.D. Searle & Co.	1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
PL198503B1 (pl)	1998-10-27	2008-06-30	Abbott Lab	Związki pirydazynonowe, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie

2001
- 2001-09-14 MY MYPI20014328A patent/MY131964A/en unknown
- 2001-09-14 TW TW090122877A patent/TWI290130B/zh not_active IP Right Cessation
- 2001-09-14 AR ARP010104370A patent/AR030741A1/es not_active Application Discontinuation
- 2001-09-15 US US09/953,049 patent/US6951889B2/en not_active Expired - Fee Related
- 2001-09-15 AU AU2001290883A patent/AU2001290883A1/en not_active Abandoned
- 2001-09-15 CZ CZ2003646A patent/CZ2003646A3/cs unknown
- 2001-09-15 AT AT01970937T patent/ATE289587T1/de active
- 2001-09-15 ES ES01970937T patent/ES2238477T3/es not_active Expired - Lifetime
- 2001-09-15 PT PT01970937T patent/PT1317421E/pt unknown
- 2001-09-15 NZ NZ524562A patent/NZ524562A/en not_active IP Right Cessation
- 2001-09-15 PL PL361137A patent/PL207391B1/pl not_active IP Right Cessation
- 2001-09-15 BR BR0113925-8A patent/BR0113925A/pt not_active IP Right Cessation
- 2001-09-15 EA EA200300377A patent/EA006244B1/ru not_active IP Right Cessation
- 2001-09-15 WO PCT/US2001/028673 patent/WO2002022562A1/en not_active Ceased
- 2001-09-15 SI SI200130343T patent/SI1317421T1/xx unknown
- 2001-09-15 KR KR1020037003786A patent/KR100840981B1/ko not_active Expired - Fee Related
- 2001-09-15 EP EP01970937A patent/EP1317421B1/en not_active Expired - Lifetime
- 2001-09-15 DE DE60109046T patent/DE60109046T2/de not_active Expired - Lifetime
- 2001-09-15 IL IL15484101A patent/IL154841A0/xx unknown
- 2001-09-15 CA CA002421504A patent/CA2421504C/en not_active Expired - Fee Related
- 2001-09-15 DK DK01970937T patent/DK1317421T3/da active
- 2001-09-15 MX MXPA03002207A patent/MXPA03002207A/es active IP Right Grant
- 2001-09-15 JP JP2002526762A patent/JP5009480B2/ja not_active Expired - Fee Related
- 2001-09-15 CN CNB018186955A patent/CN1301966C/zh not_active Expired - Fee Related
2003
- 2003-03-10 IL IL154841A patent/IL154841A/en not_active IP Right Cessation
- 2003-03-12 NO NO20031140A patent/NO20031140L/no not_active Application Discontinuation
2004
- 2004-11-01 US US10/978,817 patent/US20050113451A1/en not_active Abandoned
2005
- 2005-05-17 CY CY20051100613T patent/CY1106056T1/el unknown
2007
- 2007-08-08 AU AU2007203823A patent/AU2007203823B2/en not_active Ceased

Also Published As

Publication number	Publication date
DK1317421T3 (da)	2005-06-27
US6951889B2 (en)	2005-10-04
MY131964A (en)	2007-09-28
KR20030069167A (ko)	2003-08-25
WO2002022562A1 (en)	2002-03-21
EP1317421A1 (en)	2003-06-11
MXPA03002207A (es)	2003-06-24
AU2007203823A1 (en)	2007-09-06
HK1062910A1 (en)	2004-12-03
CN1301966C (zh)	2007-02-28
ES2238477T3 (es)	2005-09-01
PL207391B1 (pl)	2010-12-31
US20020132849A1 (en)	2002-09-19
TWI290130B (en)	2007-11-21
SI1317421T1 (no)	2005-08-31
PT1317421E (pt)	2005-07-29
NZ524562A (en)	2005-02-25
AU2007203823B2 (en)	2009-06-04
ATE289587T1 (de)	2005-03-15
IL154841A0 (en)	2003-10-31
JP2004509099A (ja)	2004-03-25
JP5009480B2 (ja)	2012-08-22
BR0113925A (pt)	2003-07-01
DE60109046D1 (de)	2005-03-31
NO20031140D0 (no)	2003-03-12
AU2001290883A1 (en)	2002-03-26
CZ2003646A3 (cs)	2003-10-15
US20050113451A1 (en)	2005-05-26
KR100840981B1 (ko)	2008-06-24
PL361137A1 (en)	2004-09-20
IL154841A (en)	2010-12-30
EA006244B1 (ru)	2005-10-27
AR030741A1 (es)	2003-09-03
DE60109046T2 (de)	2005-08-04
EP1317421B1 (en)	2005-02-23
EA200300377A1 (ru)	2003-10-30
CN1474805A (zh)	2004-02-11
CY1106056T1 (el)	2011-04-06
CA2421504C (en)	2009-11-24
CA2421504A1 (en)	2002-03-21

Legal Events

Date	Code	Title	Description
2009-04-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20031139L (no)	2003-05-09	2-amino-2-alkyl-4-heksen- og heksynsyrederivater som er anvendbare som nitrogenoksidsyntaseinhibitorer
DK1317421T3 (da)	2005-06-27	2-amino-2-alkyl-5-heptensyre- og heptynsyrederivater der er nyttige som nitrogenoxidsynthaseinhibitorer
EE200000716A (et)	2002-04-15	Lämmastikoksiidi süntaasi inhibiitorid
NO20032835L (no)	2003-08-15	Nitrogenoksyd-syntase-inhibitor-fosfatsalt
DK1265859T3 (da)	2006-05-01	Amidinoforbindelser der er nyttige som nitrogenoxidsyntaseinhibitorer
DK1347955T3 (da)	2010-06-07	Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
MXPA03000772A (es)	2003-06-04	Derivados de acido hexahidro-7-1h-azepin-2-il-hexanoico como inhibidores de oxido nitrico sintasa inducible.
DK1268480T3 (da)	2004-03-15	8-Quinolinxanthin- og 8-isoquinolinxanthinderivater som PDE5-inhibitorer
NO20026010D0 (no)	2002-12-13	Substituerte quinazolinderivater og deres anvendelse som inhibitorer
EP1282413A4 (en)	2004-12-01	6,2-AMINO-5 HALOGENATED HEPTENOIC ACID DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE INHIBITORS
NO20004531D0 (no)	2000-09-11	Halogenerte amidinoaminosyre-derivater anvendbare som nitrogenoksid syntase inhibitorer
EP1272455A4 (en)	2005-07-27	HALOGENIC DERIVATIVES OF 2-AMINO-4,5 HEPTENOIC ACID, USEFUL AS INHIBITOR OF NITRIC OXIDE SYNTHASE
AU2847200A (en)	2000-08-18	Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
EP1282420A4 (en)	2004-12-29	HALOGENED 2-AMINO-3,4-HEPTENIC ACID DERIVATE NITROGEN MONOXIDE SYNTHASE INHIBITORS
MXPA03002271A (es)	2003-06-06	Derivados de acido 2-amino-2-alquil-3-hexenoico y 2-amino-2-alquil-3-hexinoico utiles como inhibidores de oxido nitrico sintasa.
EE9900474A (et)	2000-06-15	Amidiini derivaadid lämmastikoksiidi süntaasi inhibiitoritena
NO20025884D0 (no)	2002-12-06	2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
AU2002355706A8 (en)	2008-01-03	Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
MXPA03002211A (es)	2003-06-24	Derivados de acido 2-amino-2-alquil-4-heptenoico y heptinoico utiles como inhibidores de la oxido nitrico sintasa.
MXPA03002272A (es)	2003-06-06	Derivados de acido 2-amino-2-alquil-3-heptenoico y 2-amino-2-alquil-3-heptenoico utiles como inhibidores de oxido nitrico sintasa.
DK1062201T3 (da)	2005-02-07	Halogenerede amidinoaminosyrederivater anvendelige som nitrogenoxidsynthaseinhibitirer
NO20025885D0 (no)	2002-12-06	4,5-dihydro-tiazol-2-ylaminderivater og deres anvendelse som NO-syntaseinhibitorer
AU2001282829A1 (en)	2002-03-22	Amidine derivatives which are inhibitors of nitric oxide synthase
HK1056356A (en)	2004-02-13	Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
GB0031177D0 (en)	2001-01-31	Nitric oxide synthase inhibitors